BIOMIMETIC THERAPEUTICS, INC. 4
4 · BIOMIMETIC THERAPEUTICS, INC. · Filed Mar 21, 2012
Insider Transaction Report
Form 4
BULLOCK LAWRENCE E
Chief Financial Officer
Transactions
- Purchase
Common Stock
2012-03-20$2.20/sh+17,670$38,874→ 78,723 total - Purchase
Common Stock
2012-03-19$2.20/sh+2,330$5,126→ 61,053 total
Holdings
- 28,000(indirect: By Children)
Common Stock
Footnotes (1)
- [F1]Mr. Bullock disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.